235 related articles for article (PubMed ID: 26087990)
1. Immunotherapy Approaches in Cancer Treatment.
Klener P; Otáhal P; Lateckova L; Klener P
Curr Pharm Biotechnol; 2015; 16(9):771-81. PubMed ID: 26087990
[TBL] [Abstract][Full Text] [Related]
2. Cancer immunotherapy: a treatment for the masses.
Blattman JN; Greenberg PD
Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
[TBL] [Abstract][Full Text] [Related]
3. Vaccines and immunotherapeutics for the treatment of malignant disease.
Aldrich JF; Lowe DB; Shearer MH; Winn RE; Jumper CA; Kennedy RC
Clin Dev Immunol; 2010; 2010():697158. PubMed ID: 20936120
[TBL] [Abstract][Full Text] [Related]
4. Human Tumor Antigens and Cancer Immunotherapy.
Vigneron N
Biomed Res Int; 2015; 2015():948501. PubMed ID: 26161423
[TBL] [Abstract][Full Text] [Related]
5. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of immunotherapy.
Disis ML
Semin Oncol; 2014 Oct; 41 Suppl 5():S3-13. PubMed ID: 25438997
[TBL] [Abstract][Full Text] [Related]
7. Current perspectives on immunotherapy.
Weber JS
Semin Oncol; 2014 Oct; 41 Suppl 5():S14-29. PubMed ID: 25438996
[TBL] [Abstract][Full Text] [Related]
8. Future approaches in immunotherapy.
Rini B
Semin Oncol; 2014 Oct; 41 Suppl 5():S30-40. PubMed ID: 25438998
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies in cancer immunotherapy.
Kimiz-Gebologlu I; Gulce-Iz S; Biray-Avci C
Mol Biol Rep; 2018 Dec; 45(6):2935-2940. PubMed ID: 30311129
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of Breast Cancer.
Criscitiello C; Curigliano G
Prog Tumor Res; 2015; 42():30-43. PubMed ID: 26377084
[TBL] [Abstract][Full Text] [Related]
11. Challenges and prospects of immunotherapy as cancer treatment.
Rescigno M; Avogadri F; Curigliano G
Biochim Biophys Acta; 2007 Sep; 1776(1):108-23. PubMed ID: 17720322
[TBL] [Abstract][Full Text] [Related]
12. [Cancer immunotherapy--current status].
Kundig TM; Renner Ch; Knuth A
Ther Umsch; 2006 Apr; 63(4):262-6. PubMed ID: 16689457
[TBL] [Abstract][Full Text] [Related]
13. Specific immunotherapy of cancer in elderly patients.
Matzku S; Zöller M
Drugs Aging; 2001; 18(9):639-64. PubMed ID: 11599633
[TBL] [Abstract][Full Text] [Related]
14. [Cancer immunotherapy. A future therapeutical choice?].
Bertolaccini L; Olivero G
Minerva Chir; 2001 Apr; 56(2):183-91. PubMed ID: 11353352
[TBL] [Abstract][Full Text] [Related]
15. Cancer immunotherapy.
Schuster M; Nechansky A; Kircheis R
Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
[TBL] [Abstract][Full Text] [Related]
16. [Immune alterations in lung cancer - the new therapeutic approach].
Domagała-Kulawik J; Osińska I
Pneumonol Alergol Pol; 2014; 82(3):286-99. PubMed ID: 24793154
[TBL] [Abstract][Full Text] [Related]
17. Immunogene therapy.
Lichtor T; Glick RP
Adv Exp Med Biol; 2012; 746():151-65. PubMed ID: 22639166
[TBL] [Abstract][Full Text] [Related]
18. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines.
Grau M; Walker PR; Derouazi M
Cell Mol Life Sci; 2018 Aug; 75(16):2887-2896. PubMed ID: 29508006
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells in cancer immunotherapy.
Vulink A; Radford KJ; Melief C; Hart DN
Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]